CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

New Bedford Medical Associates

New Bedford Medical Associates is a Fairhaven, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DNA2.0

DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.

LA CLINICA DE FAMILIA

LA CLINICA DE FAMILIA is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Minnesota Visiting Nurse Agency

Minnesota Visiting Nurse Agency is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atrion Corporation